Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H24BrN5O |
Molecular Weight | 442.352 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC=C(CC2=CNC(NCCCCC3=C(C)C=C(Br)C=N3)=NC2=O)C=C1
InChI
InChIKey=OGEAASSLWZDQBM-UHFFFAOYSA-N
InChI=1S/C21H24BrN5O/c1-14-9-18(22)13-25-19(14)5-3-4-8-23-21-26-12-17(20(28)27-21)10-16-7-6-15(2)24-11-16/h6-7,9,11-13H,3-5,8,10H2,1-2H3,(H2,23,26,27,28)
Molecular Formula | C21H24BrN5O |
Molecular Weight | 442.352 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Temelastine (also known as SK&F 93944) is a competitive histamine H1-receptor antagonist, which does not penetrate the central nervous system. This drug was studied as an anti-allergic agent. Experiments on animals have shown that the drug was efficacious vs. pharmacologic and antigen-induced bronchoconstriction.
CNS Activity
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2875907
In twelve subjects single oral doses of 50, 100 and 200 mg of temelastine produced dose-dependent reductions in wheal areas.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:29:24 GMT 2023
by
admin
on
Sat Dec 16 16:29:24 GMT 2023
|
Record UNII |
BF6IGI53XH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000082446
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
C049054
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
SUB10882MIG
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL70598
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
DTXSID60235437
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
X-72
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
BF6IGI53XH
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
55482
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
86181-42-2
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
C73058
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY | |||
|
5868
Created by
admin on Sat Dec 16 16:29:26 GMT 2023 , Edited by admin on Sat Dec 16 16:29:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
MAJOR
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |